Neoadjuvant Chemotherapy and Neoadjuvant Chemotherapy with Immunotherapy Result in Different Tumor Shrinkage Patterns in Triple-negative Breast Cancer
CONCLUSION: Our study demonstrates that the diffuse decrease pattern of tumor shrinkage is more common following NACI than that following NAC. Furthermore, our findings suggest that all tumor shrinkage patterns are associated with a high pCR rate in patients with TNBC treated with NACI.PMID:37985386 | DOI:10.4048/jbc.2023.0136
Source: Journal of Breast Cancer - Category: Cancer & Oncology Authors: Jiachen Zou Liulu Zhang Yuanqi Chen Yingyi Lin Minyi Cheng Xingxing Zheng Xiaosheng Zhuang Kun Wang Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Immunotherapy | MRI Scan | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Statistics | Study